Caution about ketoacidosis, UTIs, and other serious ADRs with the SGLT2s
More warnings for the SGLT2 inhibitors (Invokana, etc) will increase concerns about their safety.
These "flozins" are sometimes preferred because they have a low risk of hypoglycemia...lead to modest weight loss...and can lower BP.
Plus Jardiance (empagliflozin) has CV benefits including a reduced risk of cardiovascular death and heart failure hospitalizations.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote